Medibanx provides longitudinal clinical data with patients’ consent for faster drug development.
Medibanx has raised $255K in total funding. The most recent round was Pre-Seed. The last funding was announced in December 2022.
Medibanx's investors include FutureSight Ventures.
Medibanx is headquartered in San Francisco, United States.
Medibanx provides longitudinal clinical data with patients’ consent for faster drug development.
Medibanx is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Medibanx — Funding & Investors." VCBacked, December 10, 2022, https://www.vcbacked.co/company/medibanx. Accessed September 24, 2026.
VCBacked. (2022). Medibanx — Funding & Investors. Retrieved September 24, 2026, from https://www.vcbacked.co/company/medibanx
{{cite web |title=Medibanx — Funding & Investors |url=https://www.vcbacked.co/company/medibanx |website=VCBacked |access-date=September 24, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated